collectively, these results suggested that suppression of integrin/FAK/YAP/TAZ signals by Y15 could inhibited the laminin associated tumor progression and improved the anticancer effects of chemotherapy in vivo, which described a novel strategy for NSCLC treatment. This evidence concerns the gene PTK2 and non-small cell lung carcinoma.